The prevalence of asthma was studied in 3065 male 18 year-olds, examined in a southern Italy (Basilicata) military recruitment office. The disease was evaluated by questionnaires, pulmonary function tests and specialist diagnosis. The point prevalence of asthma was 1.4%. The disturbance was more frequent in high versus a low level of maternal education (OR: 3.70; 95% CI: 2.00-6.88), in high versus a low level of paternal education (OR: 2.71; 95% CI: 1.48-4.98), in urban residence versus rural residence (OR: 3.04; 95% CI: 1.61-5.75), in first-borns versus nonfirst-borns (OR: 2.46; 95% CI: 1.33-4.53). Home environment (dampness, heating, crowding) was not significantly correlated to asthma. This reported prevalence of asthma is low, compared with overall European and Italian data. The higher risk in urban areas and high level of education has been confirmed. The association between asthma and first-borns is interesting and needs further investigation, focusing on maternal issues like the low maternal age and the mother-child interaction.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1023/a:1007564323390 | DOI Listing |
Colomb Med (Cali)
January 2025
Universidad Internacional del Ecuador UIDE, School of Medicine, Quito, Ecuador Universidad Internacional del Ecuador Universidad Internacional del Ecuador School of Medicine Quito Ecuador.
Background: Differences in asthma prevalence between urban and rural areas have been observed worldwide. Epidemiological studies in middle- and low-income countries suggest that internal migration processes may partly explain these disparities.
Objective: To investigate the association between internal migration and asthma in children living in transitional areas of Ecuador.
J Asthma Allergy
January 2025
Department of Pediatric Gastroenterology, Fuzhou Children's Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.
Background: Cow's milk protein allergy (CMPA) is a prevalent food allergy in early childhood, significantly impacting the quality of life for affected children. Current palliative measures, such as specialized formula milk, offer temporary relief but are costly and fail to address the underlying issue. Thus, there is a critical need to better understand CMPA and explore new treatment options.
View Article and Find Full Text PDFRespir Res
January 2025
Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, USA.
Background: Air pollution is associated with poor asthma outcomes in children. However, most studies focus on ambient or indoor monitor pollution levels. Few studies evaluate breathing zone exposures, which may be more consequential for asthma outcomes.
View Article and Find Full Text PDFBMC Pregnancy Childbirth
January 2025
İzmir Bozyaka Training and Research Hospital, Department of Family Medicine, Health Sciences University, İzmir, Turkey.
Background: Maternal Near-Miss (MNM) has become globally recognized as an indicator of pregnancy, birth and the first 42 days of postpartum care services. The World Health Organization has taken a new approach to detail and better analyze maternal deaths. The clinic-based criteria to evaluate maternal care and the quality of related care services have been developed.
View Article and Find Full Text PDFPulmonology
December 2025
Portuguese Society of Pulmonology (SPP), Lisbon, Portugal.
Background: Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection, hospitalisation and death in adults.
Methods: Based on evidence regarding the impact of RSV on adult populations at risk for severe infection and the efficacy and safety of RSV vaccines, the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine endorses this position paper with recommendations to prevent RSV-associated disease and its complications in adults through vaccination.
Conclusion: The RSV vaccine is recommended for people aged ≥50 years with risk factors (chronic obstructive pulmonary disease, asthma, heart failure, coronary artery disease, diabetes, chronic kidney disease, chronic liver disease, immunocompromise, frailty, dementia, and residence in a nursing home) and all persons aged ≥60 years.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!